1. Home
  2. VTYX vs BW Comparison

VTYX vs BW Comparison

Compare VTYX & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

HOLD

Current Price

$13.99

Market Cap

990.9M

Sector

Health Care

ML Signal

HOLD

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

N/A

Current Price

$14.69

Market Cap

919.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VTYX
BW
Founded
2018
1867
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
990.9M
919.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VTYX
BW
Price
$13.99
$14.69
Analyst Decision
Hold
Buy
Analyst Count
7
3
Target Price
$13.50
$7.00
AVG Volume (30 Days)
3.4M
3.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
40.30
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.59
Revenue Next Year
N/A
$14.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.22
52 Week High
$15.34
$14.76

Technical Indicators

Market Signals
Indicator
VTYX
BW
Relative Strength Index (RSI) 72.58 76.67
Support Level $13.89 $8.03
Resistance Level $14.07 N/A
Average True Range (ATR) 0.03 0.98
MACD -0.11 0.55
Stochastic Oscillator 88.89 96.73

Price Performance

Historical Comparison
VTYX
BW

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

Share on Social Networks: